Not available
Quote | Editas Medicine Inc. (NASDAQ:EDIT)
Last: | $5.33 |
---|---|
Change Percent: | 2.11% |
Open: | $5.25 |
Close: | $5.22 |
High: | $5.39 |
Low: | $5.1299 |
Volume: | 441,467 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Editas Medicine Inc. (NASDAQ:EDIT)
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that three abstracts have been accepted for presentation, including one oral presentation, at the 27 th Annual Meeting of the American Society of G...
2024-04-21 00:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Editas Medicine Inc. (NASDAQ:EDIT)
Subject | By | Source | When |
---|---|---|---|
Could be upcoming https://annualmeeting.asgct.org/program/agenda-details?agendaI | jondoeuk | investorshub | 04/13/2023 10:21:36 PM |
Does this have any FDA approvals? | jondoeuk | investorshub | 03/19/2023 7:39:22 PM |
Does this have any FDA approvals? Will Precision | rtrstock | investorshub | 03/07/2023 6:59:07 PM |
PR https://www.globenewswire.com/news-release/2022/05/18/2445810/0/en/Editas-Med | jondoeuk | investorshub | 05/19/2022 5:39:30 PM |
1106: $EDIT-202, a Multiplexed CRISPR-Cas12a Gene-Edited iPSC-Derived NK | jondoeuk | investorshub | 05/02/2022 9:43:49 PM |
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a clinical-stage gene editing company, today announced...
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that three abstracts have been accepted for presentation, including one oral presentation, at the 27 th Annual Meeting of the American Society of G...
2024-04-21 00:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...